Natural Variation of Drug Susceptibility in Wild-Type Human Immunodeficiency Virus Type 1

Gelijkaardige items

• A Novel Phenotypic Drug Susceptibility Assay for Human Immunodeficiency Virus Type 1
  door: Petropoulos, Christos J., et al.
  Gepubliceerd in: (2000)
• The K101P and K103R/V179D Mutations in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Confer Resistance to Nonnucleoside Reverse Transcriptase Inhibitors
  door: Parkin, Neil T., et al.
  Gepubliceerd in: (2006)
• Development and Characterization of a Novel Single-Cycle Recombinant-Virus Assay To Determine Human Immunodeficiency Virus Type 1 Coreceptor Tropism
  door: Whitcomb, Jeannette M., et al.
  Gepubliceerd in: (2007)
• Reduced Susceptibility of Human Immunodeficiency Virus Type 1 (HIV-1) from Patients with Primary HIV Infection to Nonnucleoside Reverse Transcriptase Inhibitors Is Associated with Variation at Novel Amino Acid Sites
  door: Brown, Andrew J. Leigh, et al.
  Gepubliceerd in: (2000)
• Suppression of Dualtropic Human Immunodeficiency Virus Type 1 by the CXCR4 Antagonist AMD3100 Is Associated with Efficiency of CXCR4 Use and Baseline Virus Composition
  door: Fransen, Signe, et al.
  Gepubliceerd in: (2008)